Equities

International Stem Cell Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ISCO:QBB

International Stem Cell Corp

Actions
  • Price (USD)0.175
  • Today's Change0.01 / 6.06%
  • Shares traded192.00
  • 1 Year change+66.67%
  • Beta0.0818
Data delayed at least 15 minutes, as of Feb 13 2026 20:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The Company's products are based on human cell culture and types of pluripotent stem cells and hpSCs. The Company's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.

  • Revenue in USD (TTM)9.39m
  • Net income in USD-149.00k
  • Incorporated2005
  • Employees32.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VG Life Sciences Inc0.00-4.30m1.05m7.00---------0.0721-0.07210.00-0.04910.00-------384.41-294.08-----------587,591.90---1.70--------16.58------
Herborium Group Inc340.33k-318.65k1.09m2.00------3.21-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
Aditxt Inc5.95k-42.24m1.10m26.00------184.23-13,234.74-13,234.740.3444-151.860.00031.540.0304228.85-207.03-148.78---279.11-1,134.96---724,419.70-8,283.150.02-12.48-----79.23---23.40------
Halberd Corp281.24k25.34k1.13m3.000.6897--44.614.020.00230.00230.0018-0.00020.14490.03032.52--1.31--4.58--50.00--9.01--0.26611.351.02--271.52---60.11------
Pharmagreen Biotech Inc3.01k-226.26k1.26m0.00----2.28418.91-0.0003-0.00030.00-0.00350.02860.20260.0669---214.92-709.50----44.85---7,518.27-147,637.600.0375------13.67---76.59------
Exousia Pro Inc0.00-854.02k1.35m0.00---------0.0642-0.06420.00-0.03180.00-------1,313,877.00-----------------1,816.06---------248.31------
International Stem Cell Corp9.39m-149.00k1.40m32.00----8.700.1492-0.0187-0.01871.170.06551.802.6611.08293,468.80-1.13-16.11-10.84-52.8857.8659.53-0.6283-10.910.46040.62580.8632--16.64-0.8308-59.54---19.12--
GlucoTrack Inc0.00-25.85m1.50m11.00--0.5395-----1,225.32-1,225.320.003.060.00----0.00-567.22-147.48---192.87-----------3.510.5422-------218.40--34.73--
Virax Biolabs Group Ltd2.99k-5.64m1.53m19.00--0.2545--512.94-1.25-1.250.00070.81180.00040.53821.94157.37-74.60-111.16-77.64-133.38-1,515.05-4.50-189,095.00-7,009.4211.21-92.320.0959---95.95-42.409.98------
Ensysce Biosciences Inc4.49m-10.97m1.54m7.00--1.15--0.3432-6.36-6.362.320.37830.7144--5.02641,138.60-174.67-48.70-270.43-62.66-----244.49-501.34---457.150.3071--133.58--24.83------
Carisma Therapeutics Inc52.63m8.04m1.61m46.000.2047--0.16870.03060.18810.18811.26-0.02082.17----1,144,174.0033.09-26.5851.48-30.35----15.28-169.12--------31.59--30.39---1.99--
Galera Therapeutics Inc0.00-8.99m1.66m3.00---------0.1302-0.13020.00-1.940.00----0.00-129.27-96.94-145.04-116.42------------34.30------67.91------
Clearmind Medicine Inc0.00-3.86m1.68m----0.1485-----30.64-30.640.007.540.00-------57.83-128.70-178.71-360.04------------0.5987------26.60------
Agentix Corp0.00-655.59k1.68m-----------0.0164-0.01640.00-0.08530.00-------746.86-----------------7.07--------3.09------
Hcw Biologics Inc422.03k-22.21m1.76m36.00------4.16-13.96-13.960.2716-0.80380.0162--1.2411,723.06-46.35-53.89---66.1020.00---2,855.77-545.79---42.261.45---9.68---20.12---29.10--
Data as of Feb 13 2026. Currency figures normalised to International Stem Cell Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.